Respiratory Muscle Training and Intermittent Hypoxia: Additive Health Effects?
Acute Effects of Intermittent Respiratory Muscle Training and Hypoxia on Cardiovascular and Sleep Parameters in Elderly Persons With Prehypertension
1 other identifier
interventional
14
1 country
1
Brief Summary
The prevalence of pre-hypertension and hypertension in the elderly is very high. Apart from medication, physical exercise training is a potential strategy to reduce blood pressure, however, the ability to perform exercise can be limited in the elderly. Hence, alternative non-pharmacological strategies to reduce blood pressure are necessary. Two interventions that have been shown to positively influence blood pressure are respiratory muscle training (RMT) and intermittent hypoxia (IH). Whether a combination of RMT and IH yields even better effects is currently unknown. Therefore, in this study, the effect of a single session of RMT with and without IH on blood pressure and associated cardiovascular parameters will be investigated in elderly subjects with pre-hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 29, 2017
CompletedFirst Submitted
Initial submission to the registry
October 4, 2017
CompletedFirst Posted
Study publicly available on registry
October 18, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 4, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 4, 2018
CompletedAugust 15, 2018
August 1, 2018
9 months
October 4, 2017
August 14, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Change in blood pressure in mmHg
Blood pressure before, during, and after each intervention measured with an automated sphygmomanometer
At baseline after 20 min of lying in a supine position, every 5 minutes during the 60 min intervention, and 20, 35 and 50 min after the end of the intervention
Secondary Outcomes (8)
Change in pulse wave velocity in m/s
At baseline after 25 min of lying in a supine position, and 25, 40 and 55 min after the end of the intervention
Change in cardiac output in L/min
At baseline after 15min of lying in a supine position, every 5 minutes during the 60 min intervention, and 15, 30 and 45 min after the end of the intervention
Change in total peripheral resistance in dyn x s/cm^5
At baseline after 15min of lying in a supine position, every 5 minutes during the 60 min intervention, and 15, 30 and 45 min after the end of the intervention
Changes in baroreflex sensitivity in ms/mmHg
At baseline after 15min of lying in a supine position, and 15, 30 and 45 min after the end of the intervention
Change in heart rate variability in ms
At baseline after 15min of lying in a supine position, every 5 minutes during the 60 min intervention, and 15, 30 and 45 min after the end of the intervention
- +3 more secondary outcomes
Study Arms (1)
Study Group
EXPERIMENTALInterventions
RMT consists of six bouts of 5-min of volitional hyperpnoea . After each RMT bout, participants will breathe room air for 5 minutes.
RMT and IH consist of six bouts of 5-min of volitional hyperpnoea. After each RMT bout, participants will breathe a hypoxic gas mixture (10.5% O2 ) for 5 minutes.
Eligibility Criteria
You may qualify if:
- Age: 65-80 years
- Systolic blood pressure between 130-139 mmHg and diastolic blood pressure lower than 90 mmHg
- Non smoking
- Normal Body-Mass-Index (BMI): 18.5-24.9 kg·m-2
- Normal Lung Function
- Willing to adhere to the general study rules
You may not qualify if:
- Known or suspected non-compliance, drug or alcohol abuse
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
- Previous enrolment into the current study
- Enrolment of the investigator, his/her family members, employees and other dependent persons
- Intake of blood pressure medication
- Intake of medications affecting sleep or the performance or the respiratory, cardiovascular or neuromuscular system
- Acute or chronic illness other than prehypertension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Exercise Physiology Lab, Institute of Human Movement Sciences and Sport, ETH Zurich
Zurich, Canton of Zurich, 8057, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christina M. Spengler, Prof.
Exercise Physiology Lab, Institute of Human Movement Sciences and Sport, ETH Zurich
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 4, 2017
First Posted
October 18, 2017
Study Start
September 29, 2017
Primary Completion
July 4, 2018
Study Completion
July 4, 2018
Last Updated
August 15, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share